To assess the effects of valsartan and amlodipine on the haemodynamics of forearm circulation in hypertensive patients undergoing isometric stress. A total of 24 patients with essential hypertension were subjected to a double blind-cross-over study. The artery left arm flow (strain gauge plethysmography), distensibility of digital arteries (piezoelectric plethysmography) and blood pressure were measured. District resistance was calculated as the ratio between mean arterial pressure and blood flow. The tests were performed at basal conditions (T0) and after 8 days (T8) of therapy with valsartan (160 mg) or amlodipine (10 mg), at rest and during handgrip (HG); treatments were inverted after 15 days of washout. Valsartan and amlodipine reduced blood pressure after 8 days (Po0.05), handgrip increased systolic and diastolic values and heart rate at T0 and only a slight raising in diastolic values at T8. The recovery time of pressure values was longer in hypertensives treated with amlodipine (Po0.05). The forearm flow increased after HG (at T0 an T8) and increased even further after valsartan (Po0.005). Valsartan increased arteriolar distensibility, expressed by the ratio between time to peak and total time (PT/TT) calculated on the sphygmic wave. Amlodipine did not affect PT/TT ratio, whereas it reduced local resistance (T8 vs T0, Po0.05). The reduction effect of valsartan on resistance was detectable also during handgrip, on the contrary amlodipine did not control the increase. Inhibition of AT1 is able to reduce haemodynamic modifications elicited by isometric stress in hypertensive patients.
Introduction
Angiotensin II (ATII) is one of the most important acting peptides of the renin-angotensin-aldosterone system, it plays a crucial role in determining the circulatory homeostasis 1 and in the pathogenentic process of arterial hypertension. 2 ATII increases the circulatory response to sympathetic stimuli through a major expression of catecholamine receptors 3 and causes effects on the autonomic system powering sympathetic activity and depressing vagal tone. 4 The type 1 receptor is often to be found in several tissues and in particular in vessel smooth cells, its stimulation produces vasoconstriction, retention of sodium and water, with feedback on renin, smooth cell hypertrophy, vessel and myocardial fibrosis, production of superoxide, sympathetic activation, and an increase in endothelin production. 5 Valsartan is a selective antagonist of type 1 ATII receptors (AT1) which is effective in reducing arterial pressure 6 and in improving myocardial compliance. 7, 8 Some data demonstrates its efficacy in chronic heart failure. 9 Interesting data is emerging about the prevention of and the fight against the atherosclerotic process. 10 Valsartan can inhibit proinflammatory cytochines, 11 and the expression of endothelium adhesion molecules. 12 Other authors have documented the effects of ATII on modulation vessel redox state promoting nitric oxide catabolism, 13 through stimulation of superoxide anion and P-selectin expression on endothelial cells. 14 The inhibition of AT1 restores vessel properties and plays a contrasting role in the processes of vascular damage.
The importance of sympathetic activation in hypertension is well known, also enhanced nerve traffic is a characteristic feature of hypertensive patients. 15 The possibility of antagonising this activation during stress testing and through the inhibition of AT1 is not so well documented. Some studies report a reduction in sympathetic activity through AT1 inhibition in rats. 16 In our study we consider isometric stress, which can evoke an increased adrenergic output and, in addition, reduction in parasympathetic activity. 17 
Aim of the study
To evaluate the effects of AT1 inhibition on arterial pressure values and forearm haemodynamic in patients with moderate essential hypertension undergoing isometric stress.
Patients and methods

Study population
We recruited 24 subjects (20 males and four females, aged 45-55) with essential, mild to moderate, uncomplicated arterial hypertension (WHO class I-II), stable and diagnosed 4-5 years before. The diagnosis was made on the basis of the history and on clinical and laboratory criteria (including plasma and urine aldosterone, plasma renin activity and urinary catecholamines). None of these patients were smokers. No patient was suffering from heart or metabolic disease of any importance, the clinical history was negative concerning other cardiovascular diseases, they underwent electrocardiograms and tests for lipidic and glucose metabolic profiles ( Table 1 ). The female patients were not on HRT/oral contraceptive programmes. Their BMI was between 19 and 23. The fundus oculi examination showed arteries with an increased reflex (Keith-Wagener grade I), in 11 patients. The patients were informed about the nature of the study and gave their consent and they underwent a pharmacological washout lasting 15 days and drank no coffee in the 24 h before the study. The patients were randomly selected, by a randomisation list generated by specially designed software, for the two treatments (valsartan 160 mg or amlodipine 10 mg/die) which were administered for 8 days, then they were left for 15 days of washout and a crossover study for the two treatments was performed with administration of valsartan and amlodipine for 8 more days. Haemodynamic measurements were performed at baseline (T0) and after the treatments (T8), and were then repeated before and after treatment after the washout period.
The results from first treatment tests and crossover period were pooled in a whole group for each drug and expressed in the figures and tables with appropriate symbols.
The protocol was conducted in accordance with the Helsinki declaration.
Haemodynamic measurements
The haemodynamic tests were carried out at 0900 in a thermostatic chamber (22711C), after 20 0 of stabilisation in lying position. The researcher who performed the tests, was unaware of what the treatment was.
The distensibility of the digital artery was measured in the third phalanx of the left hand by means of piezoelectric plethysmography (PZ) (Angioflow plethysmograph-Microlab Padova, Italy) 18 at rest before and after treatment as a first test.
The adrenergic stimulation test used was the handgrip (HG). The patients were asked, before the tests, to grip the bladder of an aneroid dynamometer with their right hands, as hard as they could, in order to cause as great an increase in pressure as possible. During the tests the patients were asked at the appropriate moment to grip once again with a pressure which was a third of the greatest pressure and to hold that grip for at least 3 min (T0).
After 30 min of rest, HG was performed with strain gauge plethysmography (Periquant 31600 venousocclusion plethysmography, Guttman Elektronik, Eurasburg, Germany) evaluating the left forearm (not involved in the exercise); the device measured total arterial flow of the forearm every 10 s for 5 min before HG, during HG and 5 min after HG. We also studied the recovery time of the hyperflow observed after HG test.
Throughout the tests there was continuous pressure monitoring of the right arm with oscillometric equipment (Critikon-Dinamap vital sign monitor 1846 SX, Johnson & Johnson USA).
Peripheral forearm resistance was calculated as the ratio between mean blood pressure and arterial flow measured with strain gauge plethysmography (MBP/F).
Piezoelectric plethysmography is characterised by a favourable noise/signal ratio and by low impedance in the domain; 19 intraobserver variability had previously been calculated at 3.2-4.5% (mean 4%). The software used by the equipment supplies peak time (PT) and total time (TT) of the sphygmic wave and calculates the PT/TT ratio (considering a reproducible index of arteriolar distensibilitymean reproducibility 4%). [19] [20] [21] Plethysmography produces a sphygmic wave which produces a pressure-time curve, it has been studied regarding its morphology; 21 some of its features have been related to the status of the artery being examined: in particular, the slope of the raising branch of the plethysmogram and the time to peak is related to the arterial tone. 22 The ageing process and pathological conditions (hypertension, acrosyndromes, angiosclerosis) lead to a decrease in ascending branch slope, 23 that describes the distension phase of arterial wall and depends on its viscoelastic properties. 24 Furthermore, some limitations regarding piezoelectric plethysmography must be mentioned. In particular, PT depends on ventricular ejection which could be partially modified by two treatments. Secondly, PT is also influenced by wave reflection, that decreases with vasodilation; vasodilation is a property of both drugs, which has a more pronounced effect from amlodipine.
Strain-gauge plethysmography has high reproducibility and stability of measurement; the flux is measured as total blood flow and is not merely concerned with one vessel. Some limitations may mainly be due to the muscular movements of the forearm.
Statistical analysis
The data are expressed as mean7s.d. and the statistical analysis was carried out using two-tailed analysis of variance for repeated measurements (ANOVA; SPSS, SPSS Italia srl, Italy) followed by post hoc t-test for independent data (values of Po0.05 were considered to be significant), a secondary model was used to test the possibility of a carry-over effect in the postcrossover phase.
Results
Both treatments caused a significant reduction in blood pressure values at rest (Table 2) . Heart rate was unvaried at rest and increased during handgrip, no modifications were found after treatment (Table 2) .
Handgrip caused an increase in systolic and diastolic values at T0 and at T8 (Po0.05), at the end of the therapies the values were lower than those at T0 (Po0.05) ( Table 1 ).
The recovery time of the pressure values after HG was significantly reduced after therapy with valsartan while unvaried after amlodipine (Figure 1 ) (1374 vs 2475 s, Po0.04). Mean pressure at rest decreased after 8 days of therapy (97.676 vs 11073 mmHg, Po0.05) in both groups.
The flow in the forearm, when measured with strain gauge plethysmography, was unvaried before and after therapies, a slight decrease in flow was detected during HG at T0 and T8; the hyperflow in the recovery period was prolonged after valsartan (Po0.005) (Figure 2 ).
Forearm resistance (MBP/F) at rest were reduced both by valsartan and amlodipine, while only valsartan could reduce them during HG (Table 3) .
Piezoelectric plethysmography revealed a reduction in PT/TT ratio at T8 only with valsartan (Table 3) .
Discussion
Both treatments are efficacious in reducing pressure values both in rest conditions and during HG. Inhibition of AT1 is furthermore able to shorten Handgrip and AT1 inhibition in hypertensives E Arosio et al the recovery time of pressure values after a stress test. The reduction in forearm resistance is present with the two molecules, while only valsartan can control the increase in response to HG.
HG is able to elicit an increase in catecholamine release (adrenergic and noradrenergic) with a gradual increase in systolic and diastolic values. 18, 25 HG increases cardiac output and vasoconstriction, moreover, it decreases vagal output, contributing to an enhancement of sympathetic tone; 26 our results about the increase in the pressure values and resistance, confirms this data. Furthermore, during the recovery phase of pressure values, AT1 blockade produces a faster restoration; this is probably due to the abolition of ATII activity with an enhancing of the vagal tone. 17 The prolonged hyperflow detected after valsartan confirm the hyper-reactivity of vagal efferences with a reduction of resistance. The effect of amlodipine on reducing resistance is well documented, 27 and it has been confirmed by our work. Recent experimental evidence reveals that, despite the reduction of pressure, it does not reduce the 'reactivity' to several stress tests such as mental, cold pressure or isometric stress; an increase in plasma catecholamines, 28 functional cardiac load 29 and an incomplete control in pressure response during the test, at low dosages, have been documented. The increase in catecholamine plasma levels, observed by some authors, 28, 30 can also explain the difference, which occurs with valsartan in the recovery time after HG.
Valsartan favourably modulates the distensibility of the digital arteries reducing the PT/TT ratio, which is due to the blockade of AT1's vasoconstricting function and to the inhibition of sympathetic activity; ATII, on the other hand, is free to act on AT2 eliciting also vasodilation. 5, 31 The improved distensibility of the small calibre arteries is an important contribution to reduction in peripheral total resistance and to reduction in arterial stiffness; these arteries are indeed proximal to the reflection point of the sphygmic wave. 32 This data can be related to experimental evidence that demonstrates a complexity of actions on vessel tone that this class of molecules exerts, modifying the nitric oxide-angiotensin balance; 13 some authors demonstrate the increasing in release in nitric oxide after treatment with AT1 inhibitors, 33 this aspect may really have a role in improving microvascular modulation. Amlodipine, in fact, does not change the PT/TT ratio. Since plasma catecholamines and the sympathetic outflow can be activated more, during treatment with amlodipine, we hypothesise that, at this level during HG, their action may be so relevant as to suppress the directly favourable activity of amlodipine on vessel wall properties.
In conclusion, AT1 blockade is efficacious in reducing pressure values and peripheral resistance as well as Ca-channel blockade, it can, furthermore, control the increase in resistance during isometric stress leading to an improvement in vascular regulation as documented by increased post-HG hyperflow and shortened recovery time in pressure values; AT1 inhibition can also favourably modulate the distensibility of small arteries leading to benefits in terms of protection against angiosclerosis and microcirculation damage. We can so speculate that a better modulation, through AT1 blockade, of the effects of sympathetic activation could reduce vascular damage and the atherosclerotic process. What is known What the study adds 1. Several drugs can reduce pressor response to HG (betablckers, Ca-channel blockers and ACE inhibitors) 17 1. AT1 blockade is efficacious in blunting the increase in resistance during isometric stress with increased post HG hyperflow and shortened recovery time in pressure values 2. ACE inhibitors blunt sympathetic response to HG and increase flow after HG (vs beta-blockers) 16 2. AT1 blockade favourably modulates the distensibility of small arteries leading to benefits in term of protection against angiosclerosis and microcirculation damage 3. Among Ca-blockers, verapamil and felodipine documented a reduction in sympathetic response to HG vs amlodipine 30 
